TVARDI THERAPEUTICS, INC. Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer
TVARDI THERAPEUTICS, INC. (TVRD) had Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer of $4.97 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger · last filed 2025-03-11
- 2024-09-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer $4.97M.
- 2024-06-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer $7.38M.
- 2024-03-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer $7.31M.
- 2023-12-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer $9.24M.
| Period end | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer |
|---|---|
| 2024-09-30 | $4.97M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $7.38M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $7.31M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $9.24M 10-K · filed 2025-03-11 |
| 2023-09-30 | $16.56M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $36.38M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $56.02M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $62.18M 10-K · filed 2024-03-06 |
| 2022-09-30 | $33.74M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $10.33M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $7.36M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $3.04M 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |